📈 Trauma Implants Market to Reach $15.2 Billion by 2031 Amid Rising Road Injuries and Aging Population

June 19, 2025 04:18 PM AEST | By EIN Presswire
 📈 Trauma Implants Market to Reach $15.2 Billion by 2031 Amid Rising Road Injuries and Aging Population
Image source: EIN Presswire
PORTLAND, OR, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- The global trauma implants market, valued at $8.4 billion in 2021, is projected to grow to $15.2 billion by 2031, expanding at a CAGR of 6.1%. This growth is primarily driven by a surge in road traffic accidents, increasing geriatric population, and advancements in implant technology.

🔍 Market Drivers
Rise in Road Accidents: Road injuries remain a major cause of bone fractures. According to NCRB, India recorded 437,396 road accident cases in 2019, while the U.S. saw a 10.5% increase in accidents in 2021.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17527

Growing Elderly Population: WHO estimates that the number of people aged 60 and older will rise from 1 billion in 2019 to 1.4 billion by 2030, increasing vulnerability to fractures.

Innovation by Key Players: Companies like Johnson & Johnson and Stryker are investing in advanced R&D, launching new products such as 2.7 mm Variable Angle Locking Compression Plate for fracture treatment.

🧬 Market Segmentation Highlights
By Product:

Screws led in 2021 due to high demand in tibial fracture treatment.

Bioabsorbable fixators are gaining popularity for their ability to stabilize bones and naturally degrade.

By Material:

Metallic biomaterials (titanium, stainless steel) dominate the market.

Bioabsorbable materials such as PLA and PGA are expected to see significant growth.

By End User:

Hospitals held the largest share in 2021.

Orthopedic centers are expected to grow steadily due to increased specialized surgeries.

By Region:

North America dominates the market due to robust infrastructure and strong company presence.

Asia-Pacific is expected to register fast growth, driven by increased healthcare investments and awareness.

⚠️ Challenges
High Cost of Surgery: Trauma implant procedures remain expensive, limiting access in low-income regions.

Side Effects: Risk of infections, implant rejection, and post-surgical pain may deter some patients.

Regulatory Hurdles: Strict government approval procedures slow down market entry for new products.

🤝 Competitive Landscape
Key players shaping the trauma implants market include:
B. Braun Melsungen AG, Bioretec Ltd, Acumed, Conformis Inc., Globus Medical, J&J (DePuy Synthes), Medtronic, Orthofix, Siora Surgicals, Smith & Nephew, Stryker, and Zimmer Biomet.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A17527

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.